Valuation: Divi's Laboratories Limited

Market Cap 2,22400Cr 2.34TCr 2.03TCr 1.89TCr 1.74TCr 3.29TCr 3.32TCr 22TCr 8.72TCr 1,11200Cr 8.78TCr 8.59TCr 3,68400Cr P/E 2027 *
68.7x
P/E 2028 * 57.1x
Enterprise Value 2,18900Cr 2.3TCr 2TCr 1.86TCr 1.71TCr 3.24TCr 3.27TCr 22TCr 8.59TCr 1,09400Cr 8.64TCr 8.45TCr 3,62600Cr EV / Sales 2027 *
17.5x
EV / Sales 2028 * 14.6x
Free-Float
48%
Yield 2027 *
0.42%
Yield 2028 * 0.49%
1 day+0.08%
1 week+7.71%
Current month+4.08%
1 month+22.27%
3 months+26.07%
6 months+36.53%
Current year+31.17%
1 week 7,795
Extreme 7795
8,585
1 month 6,693
Extreme 6693
8,585
Current year 5,647.5
Extreme 5647.5
8,585
1 year 5,636.5
Extreme 5636.5
8,585
3 years 3,295.3
Extreme 3295.3
8,585
5 years 2,730
Extreme 2730
8,585
10 years 532.65
Extreme 532.65
8,585
Manager TitleAgeSince
Chief Executive Officer 75 26/11/2009
Chief Executive Officer 48 04/01/2020
Director of Finance/CFO 65 01/08/2025
Director TitleAgeSince
Director/Board Member 48 26/11/2009
Chairman 75 26/11/2009
Director/Board Member 68 01/10/1994
Date Insider Type Main position Quantity % Market Cap.
26/03/25 Sell

Executive/Senior Manager

25,000 0.0094%
15/03/25 Sell 300 0.0001%
17/02/25 Sell 500 0.0002%
Change 5-day change 1-year change 3-year change Capi.($)
+0.08%+7.71%+30.83%+114.42% 2.34TCr
-0.51%-8.60%+45.08%+148.21% 99TCr
+0.20%-4.42%+49.05%+50.81% 61TCr
-0.53%-7.37%+23.64%+65.03% 43TCr
+0.59%-0.36%+41.11%+36.08% 35TCr
-0.29%-4.16%+30.24%+38.39% 29TCr
-1.23%-11.39%+3.73%+6.91% 24TCr
-3.88%-12.23%-3.01%-45.63% 21TCr
+2.94%-0.78%+29.17%+60.32% 21TCr
+3.13%+0.69%+18.11%+71.90% 17TCr
Average +0.11%-3.23%+26.80%+54.64% 35.42TCr
Weighted average by Cap. +0.12%-5.77%+33.52%+70.65%

Financials

2027 *2028 *
Net sales 13TCr 131.65Cr 114.32Cr 106.59Cr 98Cr 185.18Cr 187.21Cr 1.26TCr 491.23Cr 6.26TCr 494.4Cr 483.57Cr 21TCr 15TCr 156.92Cr 136.25Cr 127.04Cr 116.7Cr 220.72Cr 223.14Cr 1.5TCr 585.5Cr 7.46TCr 589.28Cr 576.37Cr 25TCr
Net income 3.24TCr 34Cr 30Cr 28Cr 25Cr 48Cr 48Cr 325.12Cr 127.1Cr 1.62TCr 127.92Cr 125.11Cr 5.37TCr 3.9TCr 41Cr 36Cr 33Cr 30Cr 58Cr 58Cr 391.28Cr 152.96Cr 1.95TCr 153.95Cr 150.57Cr 6.46TCr
Net Debt -3.5TCr -37Cr -32Cr -30Cr -27Cr -52Cr -52Cr -351.19Cr -137.29Cr -1.75TCr -138.17Cr -135.14Cr -5.8TCr -4.49TCr -47Cr -41Cr -38Cr -35Cr -66Cr -67Cr -450.06Cr -175.94Cr -2.24TCr -177.08Cr -173.2Cr -7.43TCr
Logo Divi's Laboratories Limited
Divi's Laboratories Limited is specialized in the development and manufacture of active pharmaceutical ingredients, intermediates and nutraceutical ingredients. Net sales by source of revenue break down into product sales (97.9%) and service sales (2.1%). At the end of March 2020, the group has 2 production sites located in India.
Employees
11,565
Date Price Change Volume
05/26/05 8,398.00 +0.24% 2,50,837
04/26/04 ₹8,378.00 -2.41% 9,70,329
03/26/03 ₹8,585.00 +6.57% 17,98,150
31/26/31 ₹8,056.00 +2.82% 7,93,919
30/26/30 ₹7,835.00 +0.65% 6,51,446
Trader
Investor
Global
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
30
Last Close Price
8,378.00INR
Average target price
8,107.03INR
Spread / Average Target
-3.23%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. DIVISLAB Stock